826 filings
Page 4 of 42
20-F
2022 FY
KZIA
Kazia Therapeutics Limited
Annual report (foreign)
17 Oct 22
7:09am
6-K
KZIA
Kazia Therapeutics Limited
14 Oct 22
Current report (foreign)
7:05am
6-K
KZIA
Kazia Therapeutics Limited
15 Sep 22
Current report (foreign)
9:12am
6-K
KZIA
Kazia Therapeutics Limited
8 Sep 22
Current report (foreign)
5:06pm
6-K
KZIA
Kazia Therapeutics Limited
1 Sep 22
Current report (foreign)
4:07pm
6-K
KZIA
Kazia Therapeutics Limited
5 Aug 22
Kazia Therapeutics Reports Promising Interim Data from Combination Study of Paxalisib with Radiotherapy In Treatment of Brain Metastases
8:18am
6-K
KZIA
Kazia Therapeutics Limited
1 Aug 22
Kazia Provides Progress Update on GBM Agile Pivotal Study
8:51am
6-K
KZIA
Kazia Therapeutics Limited
6 Jul 22
Current report (foreign)
6:04am
6-K
KZIA
Kazia Therapeutics Limited
30 Jun 22
Current report (foreign)
6:04am
6-K
KZIA
Kazia Therapeutics Limited
23 Jun 22
Current report (foreign)
7:40am
6-K
KZIA
Kazia Therapeutics Limited
17 Jun 22
Us Fda Awards Orphan Drug Designation (Odd) to Paxalisib
4:54pm
UPLOAD
KZIA
Kazia Therapeutics Limited
28 Apr 22
Letter from SEC
12:00am
6-K
KZIA
Kazia Therapeutics Limited
22 Apr 22
Current report (foreign)
4:06pm
424B5
KZIA
Kazia Therapeutics Limited
22 Apr 22
Prospectus supplement for primary offering
4:04pm
CORRESP
KZIA
Kazia Therapeutics Limited
20 Apr 22
Correspondence with SEC
12:00am
6-K
KZIA
Kazia Therapeutics Limited
5 Apr 22
Current report (foreign)
6:08am
6-K
KZIA
Kazia Therapeutics Limited
24 Mar 22
Current report (foreign)
6:06am
UPLOAD
KZIA
Kazia Therapeutics Limited
22 Mar 22
Letter from SEC
12:00am
6-K
KZIA
Kazia Therapeutics Limited
13 Dec 21
Current report (foreign)
6:13am
6-K
KZIA
Kazia Therapeutics Limited
3 Dec 21
Current report (foreign)
6:22am